Digitally Unleashing Your Molecular Superpowers
Digital tools can augment pathologists’ molecular medicine powers so they can diagnose and treat more patients
Nick Lench | | Opinion
With its potential to revolutionize diagnosis, treatment, and outcomes for patients across multiple clinical indications, demand for next-generation sequencing (NGS) is increasing rapidly. But interpreting sequenced data – complex, lengthy, and costly – presents a bottleneck to widespread routine clinical adoption. To compound the problem, the interpretation of genetic results often still relies heavily on labor-intensive processes that only highly trained clinical scientists can offer.
Initially, we believed that achieving the US$1,000 genome would make whole-genome sequencing a reality in the clinic – but that price point only reflects the cost of generating sequence data, not the staff time, sample processing, or bioinformatic processing and interpretation required to perform this complex task. As NGS accessibility continually increases, we realize that expert interpretation is the new bottleneck. The need to augment the available expertise with automated tools is becoming increasingly apparent.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine